Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -22.27x is in line with its 2-year average of -20.64x, around the middle of its 2-year range (-26.15x–-15.48x).
As of the fiscal period ended Thursday, June 30, 2022.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2022 (2022-06-30): -22.27x.
INTEREST COVERAGE RATIO
-22.27x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-249.33%
vs the sector median at left
Dianthus Therapeutics, Inc.
Market Cap
$4.72B
Interest Coverage Ratio
-22.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Interest Coverage Ratio
2.07x
TTM Avg
2.07x
3Y Avg
2.07x
5Y Avg
1.38x
Market Cap
$4.67B
Interest Coverage Ratio
-30.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.77B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.78B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65B
Interest Coverage Ratio
5.35x
TTM Avg
5.33x
3Y Avg
5.03x
5Y Avg
4.13x
Market Cap
$4.64B
Interest Coverage Ratio
168.66x
TTM Avg
168.66x
3Y Avg
168.66x
5Y Avg
168.66x
Market Cap
$4.46B
Interest Coverage Ratio
5.89x
TTM Avg
3.33x
3Y Avg
3.33x
5Y Avg
4.95x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.72B | -22.27x | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 2.07x | 2.07x | 2.07x | 1.38x |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.67B | -30.34x | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.77B | -1.54x | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.78B | N/A | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 5.35x | 5.33x | 5.03x | 4.13x |
| BillionToOne, Inc. (BLLN)vs › | $4.64B | 168.66x | 168.66x | 168.66x | 168.66x |
| Erasca, Inc. (ERAS)vs › | $4.94B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.46B | 5.89x | 3.33x | 3.33x | 4.95x |
| Waystar Holding Corp. (WAY)vs › | $5.03B | 3.22x | 2.04x | 1.33x | 1.16x |
Interest Coverage
-22.3x
Debt/Equity
0.00
Current Ratio
26.10
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | -22.27x |
| 2021-03-31 | -15.48x |
| 2020-12-31 | -21.25x |
| 2020-09-30 | -26.15x |
| 2020-06-30 | -21.45x |
| 2020-03-31 | -17.23x |
